CClinicalTrials.gg
CompletedNCT02243410Updated Sep 17, 2014

Visual Analogue Scale - a Quality Assurance Study

An observational study in Surgery, sponsored by Herlev Hospital. Completed at 1 site in Denmark. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-09-17.

Sponsored by Herlev Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
62
Ages
18 Years and older
Sex
All
01

Study summary

It has come to our attention that there is not a general consensus of how to apply Visual Analogue Scale (VAS) as a tool in measuring pain amongst postoperative patients in Denmark.

The assumption is that patients will grade the level of pain differently dependent on how VAS is presented.

Read the detailed description

To ensure the data is valid for the study it has been decided to base the research material on four different VAS usage, as it is most often used in clinical practise in Denmark. Which in this case implies VAS horizontal, with and without endpoint, and VAS vertical, with and without endpoint. Every participant will grade their pain on each of the listed VAS representations. Furthermore, as a guideline, the participant will be asked to grade the pain on a Numerical Ranking Scale (NRS).

The ordering of VAS lines will be subject to randomization, for each participant

02

Conditions studied

  • Surgery
03

In context

Lead sponsor

Herlev Hospital is the lead sponsor of 195 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

All participants will be postoperative patients of Department of Surgery, Department of Gynecology and Department of Orthopaedic Surgery, all based at Herlev Hospital.

Inclusion criteria

  • Patient must have undergone surgery within the last five days
  • The patient must be able and willing to participate in the study
  • Must be at 18 years of age or older
  • A patient can only participate one time.

Exclusion criteria

Exclusion Criteria:

  • Previously included patients
  • Medically treated patients Linguistic difficulties
  • Mentally or physically exhausted
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
62 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. agreement in VAS values with horizontal vs vertical and with and without stop lines

    Time frame: First five days after surgery

07

Study locations

1 site
  • Herlev Hospital
    Herlev, 2730, Denmark
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 17, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02243410
Lead sponsor
Herlev Hospital
Responsible party
Jacob Rosenberg (Professor, Herlev Hospital) — Principal investigator
First posted
Sep 17, 2014
Start date
Mar 2014
Primary completion
Sep 2014
Completion
Sep 2014
Last update
Sep 17, 2014

Study contacts

Jacob Rosenberg, MD
study chair · Professor

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion